Hemispherian AS (“Hemispherian” or the “Company”), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to …
https://finance.yahoo.com/news/hemispherian-raises-first-tranche-series-080000505.html